Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

In vivo CRISPR screen reveals interplay of epigenetic regulators underlies kinetics of hepatobiliary reprogramming [RNA-Seq]

ABSTRACT: In vivo CRISPR screen reveals interplay of epigenetic regulators underlies kinetics of hepatobiliary reprogramming [RNA-Seq]

PROVIDER: PRJNA1127022 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

In vivo CRISPR screen reveals interplay of epigenetic regulators underlies kinetics of hepatobiliary reprogramming [CUT&Tag]

Project description:In vivo CRISPR screen reveals interplay of epigenetic regulators underlies kinetics of hepatobiliary reprogramming [CUT&Tag]

| PRJNA1127021 | ENA

In vivo CRISPR screen reveals interplay of epigenetic regulators underlies kinetics of hepatobiliary reprogramming [CUT&Tag]

Project description:Under chronic liver injury, a small fraction of hepatocytes undergoes reprogramming to biliary epithelial cells (BECs) through a multistep process of chromatin and transcriptional remodeling in which the hepatocyte phenotype is repressed and the biliary phenotype is activated. However, the epigenetic basis underlying this phenomenon is largely unknown. Here, using a lineage-traced model of cholestatic liver injury, we investigated the role of histone posttranslational modification in the kinetics of biliary reprogramming. In this study, we performed CUT&Tag to profile the changes in histone landscape throughout reprogramming and explored the impact of Nsd1 and Kdm2a knockout.

2025-01-01 | GSE270508 | GEO

In vivo CRISPR screen reveals interplay of epigenetic regulators underlies kinetics of hepatobiliary reprogramming [RNA-Seq]

Project description:Under chronic liver injury, a small fraction of hepatocytes undergoes reprogramming to biliary epithelial cells (BECs) through a multistep process of chromatin and transcriptional remodeling in which the hepatocyte phenotype is repressed and the biliary phenotype is activated. However, the epigenetic basis underlying this phenomenon is largely unknown. Here, we profiled cells after knockout of Nsd1 or Kdm2a at two reprogramming stages to assess the transcriptional differences imposed by epigenetic dysregulation.

2025-01-01 | GSE270509 | GEO

Plasma Proteome for Hepatobiliary Carcinomas

Project description:This project is to identify plasma glycoprotein markers for hepatobiliary cancers

2019-11-12 | PXD013629 | Pride

Functional interplay between SWI/SNF complexes underlies BRD9 dependency in SMARCB1-mutant cancers

Project description:Functional interplay between SWI/SNF complexes underlies BRD9 dependency in SMARCB1-mutant cancers

| PRJNA866519 | ENA

Proteomic Analysis of Canine Hepatobiliary Neuroendocrine Neoplasms

Project description:Neuroendocrine neoplasms of the gallbladder and liver occur rarely in dogs and humans. A recent reclassification of human neuroendocrine neoplasms by the World Health Organization has refined categorization of these tumors by morphology, replicative indices, and molecular signatures. In humans, these factors correlate with survival outcomes. Improved characterization of these tumors is needed in dogs to identify diagnostic biomarkers and determine therapeutic strategies. To achieve this objective, the proteome of 3 canine hepatobiliary neoplasms was compared to normal canine adrenal and liver tissue from formalin-fixed paraffin-embedded samples. Thirty-two upregulated and 121 downregulated differentially expressed proteins were identified in the hepatobiliary neuroendocrine neoplasm samples. Among the upregulated proteins is galectin-1, a multivalent carbohydrate binding protein known to play a role in lung and pancreatic neuroendocrine neoplasia development and progression in humans. Drugs targeting the galectin family have shown promise as anticancer therapeutics in cervical cancer, prostate cancer, lung and pancreatic neuroendocrine neoplasia in human medicine. Galectin-1 may represent a novel treatment target in hepatobiliary neuroendocrine neoplasia in both humans and dogs.

2023-03-11 | PXD028822 | Pride

Plasma Proteome for Hepatobiliary Carcinomas

Project description:This project is to identify plasma glycoprotein markers for hepatobiliary cancers

2020-08-31 | MSV000086047 | MassIVE

PerturbSci-Kinetics: Dissecting key regulators of transcriptome kinetics through scalable single-cell RNA profiling of pooled CRISPR screens

Project description:Here we described PerturbSci-Kinetics, a novel combinatorial indexing method for capturing three-layer single-cell readout (i.e., nascent transcriptome, whole transcriptome, sgRNA identities) across hundreds of genetic perturbations. Through PerturbSci-Kinetics profiling of pooled CRISPR screens, we were able to decipher the complexity of RNA dynamics (e.g., synthesis, splicing, and degradation) at both global and gene-specific levels. Our technique opens up the possibility to perform genome-wide perturbations across millions of single cells cost-effectively.

2023-08-10 | GSE218566 | GEO

Functional interplay between SWI/SNF complexes underlies BRD9 dependency in SMARCB1-mutant cancers [RNA-seq]

Project description:Functional interplay between SWI/SNF complexes underlies BRD9 dependency in SMARCB1-mutant cancers [RNA-seq]

| PRJNA866525 | ENA

Functional interplay between SWI/SNF complexes underlies BRD9 dependency in SMARCB1-mutant cancers [CUT & RUN]

Project description:Functional interplay between SWI/SNF complexes underlies BRD9 dependency in SMARCB1-mutant cancers [CUT & RUN]

| PRJNA866526 | ENA